Rank #1805ARCT

Arcturus Therapeutics Holdings

$7.97

6.13% (Daily)

Market Cap

$226.46M

Revenue

$97.60M

Rank by MCap

#1805

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Joseph E. Payne M.Sc.

Headquarters

San Diego, CA

Employees

174

About Arcturus Therapeutics Holdings

Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial f...